The Taipei Medical University Shuang-Ho Hospital is a hospital in Zhonghe District, New Taipei, Taiwan. It is the affiliated hospital of Taipei Medical University.

There are 1,500 beds in Shuang Ho Hospital.

During the past decade, Shuang Ho Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shuang Ho Hospital" #1 sponsor was "Taipei Medical University Shuang Ho Hospital" with 5 trials, followed by "Taipei Medical University" with 2 trials sponsored, "Taipei Medical University WanFang Hospital" with 2 trials sponsored, "Academia Sinica, Taiwan" with 1 trials sponsored and "Athenex, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shuang Ho Hospital" #1 collaborator was "Caris Life Sciences" with 1 trials as a collaborator, "Chang Gung Memorial Hospital" with 1 trials as a collaborator, "China Medical University Hospital" with 1 trials as a collaborator, "Chung Shan Medical University" with 1 trials as a collaborator and "IRCAD-Taiwan" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Shuang Ho Hospital" are "Inflammation" (2 trials), "Solid Tumor" (2 trials), "Stroke" (2 trials), "Aging" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Shuang Ho Hospital" in a lesser frequency.

Most popular intervention types in "Shuang Ho Hospital" are "Drug" (6 trials), "Other" (5 trials), "Device" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma" (1 trials), "Aerobic exercise" (1 trials), "Azacitidine" (1 trials), "BCAA supplement" (1 trials) and "BEEP regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shuang Ho Hospital" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shuang Ho Hospital". 1 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Shuang Ho Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shuang Ho Hospital, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".